Vaccine News and Research

Latest Vaccine News and Research

Acquired immune thrombotic thrombocytopenic purpura develops after vaccination with CoronaVac

Researchers from the Second Affiliated Hospital of Nanjing Medical University, et al. have published a case report entitled "Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine CoronaVac". This report was published in Frontiers of Medicine, Volume 18, Issue 4, 2024.

17 Nov 2025

Are mushrooms more than a low-calorie food? New analysis explains their hidden advantages

Whole mushroom consumption shows consistent benefits for cardiometabolic health, lowering triglycerides in self-chosen diets and improving fasting glucose in a single healthy dietary pattern trial. Early evidence also suggests increases in salivary IgA and possible blood pressure improvements, with no adverse biomarker effects reported.

16 Nov 2025

Enhancing the cancer-immunity cycle through innovative vaccines

Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in oncology toward harnessing the immune system's intrinsic ability to combat malignancies.

14 Nov 2025

Conflicting advice on covid shots likely to ding already low vaccine rates, experts warn

More than three-quarters of American adults didn't get a covid shot last season, a figure that health care experts warn could rise this year amid new U.S. government recommendations.

14 Nov 2025

Ending human bait practices in river blindness monitoring

New research shows that it's possible to end the practice of using people as 'human bait' to catch and test the blackflies that spread river blindness (onchocerciasis).

13 Nov 2025

Funding challenges threaten to reverse global gains in the fight against TB

Tuberculosis (TB) remains one of the world's deadliest infectious killers, claiming over 1.2 million lives and affecting an estimated 10.7 million people last year, according to the WHO Global Tuberculosis Report 2025, released today.

13 Nov 2025

Study links common Epstein-Barr virus to autoimmune lupus

One of humanity's most ubiquitous infectious pathogens bears the blame for the chronic autoimmune condition called systemic lupus erythematosus or, colloquially, lupus, Stanford Medicine investigators and their colleagues have found.

12 Nov 2025

Nasal vaccine shows promise as a non-invasive treatment for cervical cancer

Cervical cancer, which affects the reproductive tract, is one of the most common cancers in women worldwide.

12 Nov 2025

New typhoid conjugate vaccine shows safety and strong immune response in Africa

PATH and EuBiologics Co., LTD are pleased to announce Phase 3 results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj.® Multi-dose. EuTYPH-C Inj.®

12 Nov 2025

Age and flu vaccine type influence immune activation

New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune system that help to protect against infection varied greatly depending on the vaccine type and age of the patient.

12 Nov 2025

Prior exposure to cold viruses boosts antibody response against SARS-CoV-2

Prior exposure to coronaviruses that cause ordinary colds can boost the immune system's ability to attack a vulnerable site on the COVID-19-causing coronavirus SARS-CoV-2, according to a study led by investigators at Weill Cornell Medicine.

11 Nov 2025

Nanoparticle vaccine eliminates HPV-induced tumors in animal model

A nanoparticle vaccine designed to fight cancers induced by human papillomavirus (HPV) eradicated tumors in an animal model of late-stage metastatic disease, UT Southwestern Medical Center scientists report in a new study published in the Proceedings of the National Academy of Sciences (PNAS).

11 Nov 2025

Groundbreaking vaccination approach could transform respiratory disease prevention

A research team from Trinity College Dublin has unveiled a groundbreaking new approach to vaccination that could redefine how we protect against respiratory infections.

10 Nov 2025

New delivery particle could make mRNA vaccines cheaper and more effective

A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine dose.

7 Nov 2025

Immigrants with health conditions may be denied visas under new Trump administration guidance

Foreigners seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or obesity, under a Thursday directive from the Trump administration.

6 Nov 2025

COVID-19 vaccination linked to lower long COVID risk in adolescents

Adolescents who were vaccinated against COVID-19 were less likely to develop long COVID after their first SARS-CoV-2 infection than unvaccinated peers, finds a new study.

6 Nov 2025

Low-dose THC mitigates harmful side effects and inflammation caused by HIV treatment

Long-term, low doses of THC mitigate many harmful side effects and inflammation caused by HIV and antiretroviral therapy (ART), according to new research from Texas Biomedical Research Institute.

6 Nov 2025

Evolving epidemiology of invasive Group A Streptococcus in critical care

Streptococcus pyogenes or invasive Group A Streptococcus (iGAS) is a major clinical concern around the world, since iGAS infections can quickly escalate into life-threatening conditions such as necrotizing fasciitis, septic shock, and pneumonia.

6 Nov 2025

COVID-19 vaccination may have broader health benefits for children with atopic dermatitis

Children with atopic dermatitis (AD), commonly known as eczema, may experience fewer infections and allergic complications if they receive the COVID-19 vaccine, according to new research being presented at the 2025 American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Orlando.

6 Nov 2025

Experimental intranasal vaccine triggers broad immune response against multiple strains of H5N1

Researchers at the University of Maryland School of Medicine's Center for Vaccine Development and Global Health (CVD) reported encouraging results from an early phase clinical trial that found an experimental intranasal vaccine triggered a broad immune response against multiple strains of H5N1 "bird flu".

6 Nov 2025

Vaccine News and Research

Latest Vaccine News and Research

Acquired immune thrombotic thrombocytopenic purpura develops after vaccination with CoronaVac

Are mushrooms more than a low-calorie food? New analysis explains their hidden advantages

Enhancing the cancer-immunity cycle through innovative vaccines

Conflicting advice on covid shots likely to ding already low vaccine rates, experts warn

Ending human bait practices in river blindness monitoring

Funding challenges threaten to reverse global gains in the fight against TB

Study links common Epstein-Barr virus to autoimmune lupus

Nasal vaccine shows promise as a non-invasive treatment for cervical cancer

New typhoid conjugate vaccine shows safety and strong immune response in Africa

Age and flu vaccine type influence immune activation

Prior exposure to cold viruses boosts antibody response against SARS-CoV-2

Nanoparticle vaccine eliminates HPV-induced tumors in animal model

Groundbreaking vaccination approach could transform respiratory disease prevention

New delivery particle could make mRNA vaccines cheaper and more effective

Immigrants with health conditions may be denied visas under new Trump administration guidance

COVID-19 vaccination linked to lower long COVID risk in adolescents

Low-dose THC mitigates harmful side effects and inflammation caused by HIV treatment

Evolving epidemiology of invasive Group A Streptococcus in critical care

COVID-19 vaccination may have broader health benefits for children with atopic dermatitis

Experimental intranasal vaccine triggers broad immune response against multiple strains of H5N1

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Newsletters you may be interested in